Stock Analysis, Dividends, Split History

IVTY / Invuity, Inc. financial ratios include Market Cap, Enterprise Value, Book Value, Quick Ratio, Current Ratio, NCAV, EBITDA, Profit Margin, Operating Margin, Return on Invested Capital (ROIC), Return on Assets (ROA), Return on Equity (ROE), Piotroski F-Score, Altman Z-Score, Beneish M Score and Kaplan-Zingales KZ-Index.

Valuation Metrics
Price3.40
Volume111,700.00
Market Cap ($M)84.26
Enterprise Value ($M)94.57
Book Value ($M)2.33
Book Value / Share0.10
Price / Book36.13
NCAV ($M)-5.46
NCAV / Share-0.23
Price / NCAV-14.98
Share Statistics
Common Stock Shares Outstanding 17,179,258
Common Shares Outstanding 17,204,000
Preferred Stock Shares Outstanding 0
Scoring Models
Piotroski F-Score1.00
Altman Z ScoreN/A
Beneish M ScoreN/A
Management Effectiveness (mra)
Return on Invested Capital (ROIC)-1.41
Return on Assets (ROA)-0.66
Return on Equity (ROE)-1.16
Balance Sheet (mrq) ($M)
Assets48.73
Liabilities46.40
Quick Ratio1.69
Current Ratio2.13
Income Statement (mra) ($M)
Minimum Net Revenue Requirements Period140,488,151.00
Minimum Net Revenue Requirements Period242,248,214.00
Minimum Net Revenue Requirements Period346,574,986.00
Revenues39,619,000.00
Minimum Net Revenue Requirements Period450,000,000.00
Operating Income-35.26
Net Income-39.92
Earnings Per Share Basic And Diluted-2.34
Cash Flow Statement (mra) ($M)
Cash From Operations-38.88
Cash from Investing6.87
Cash from Financing6.87
Identifiers and Descriptors
CUSIP46187J205
Central Index Key (CIK)1393020

Split History

Stock splits are used by Invuity, Inc. to keep share prices within reasonable numbers to encourage investment. If the share price of a security gets too high, a company can perform a stock split by issuing all shareholders an extra share, thereby halving the price of an individual share. If the share price gets too low, companies can do reverse splits. This is common when share prices drop below $1.00 and company's become in danger of being delisted. However, because of the cost, stock splits are not a normal business occurrence.

Coming soon

Related Articles

BLDP: Ballard Power Systems Analysis and Research Report

2018-08-13 - Asif

Core Business At Ballard, Ballard Power Systems is building a clean energy growth company. Ballard Power Systems is recognized as a world leader in proton exchange membrane (“PEM”) fuel cell power system development and commercialization. The company's principal business is the design, development, manufacture, sale and service of PEM fuel cell products for a variety of applications, focusing on its power product markets of Heavy-Duty Motive (consisting of bus, truck, rail and marine applications), Portable Power, Material Handling and Backup Power, as well as the delivery of Technology Solutions, including engineering services, technology transfer, and the license and sale of its extensive intellectual property portfolio and fundamental knowledge for a variety of fuel cell applications. A fuel cell is an environmentally clean electrochemical device that combines hydrogen fuel with oxygen (from the air) to produce electricity. The hydrogen fuel can be obtained from natural g...

MARA: Marathon Patent Group Analysis and Research Report

2018-08-13 - Asif

Overview Marathon Patent Group was incorporated in the State of Nevada on February 23, 2010 under the name Verve Ventures, Inc. On December 7, 2011, the company changed its name to American Strategic Minerals Corporation and were engaged in exploration and potential development of uranium and vanadium minerals business. In June 2012, the company discontinued its minerals business and began to invest in real estate properties in Southern California. In October 2012, the company discontinued its real estate business when its former CEO joined the firm and the company commenced its IP licensing operations, at which time the Company’s name was changed to Marathon Patent Group, Inc. On November 1, 2017, the company entered into a merger agreement with Global Bit Ventures, Inc. (“GBV”), which is focused on mining digital assets. Marathon Patent Group has since purchased its cryptocurrency mining machines and established a data center in Canada to mine digital assets. Following the me...

ECYT: Endocyte Analysis and Research Report

2018-08-13 - Asif

Business and Organization Endocyte, Inc. is a biopharmaceutical company and leader in developing targeted therapies for the treatment of cancer. The Company uses drug conjugation technology to create novel therapeutics and companion imaging agents for personalized targeted therapies. The agents actively target receptors that are over-expressed on diseased cells relative to healthy cells, such as prostate specific membrane antigen (“PSMA”) in prostate cancer. This targeted approach is designed to safely enable the delivery of highly potent drug payloads. The companion imaging agents are designed to identify patients whose disease over-expresses the target of the therapy and who are therefore more likely to benefit from treatment. In September 2017, the Company entered into a Development and License Agreement (the “License Agreement”) with ABX advanced biochemical compounds – Biomedizinische Forschungsreagenzien GmbH (“ABX”), pursuant to which the Company acquired exclusive ...

Related News Stories

Invuity, Inc. (IVTY) CEO Scott Flora on Q2 2018 Results - Earnings Call Transcript

2018-08-03 seekingalpha
Good day, ladies and gentlemen, and welcome to the Q2 2018 Invuity, Inc., Earnings Conference Call. At this time, all participations are in a listen only mode. Later, we will conduct a question-and-answer session and instructions will follow at that time. [Operator Instructions] As a reminder, this conference is being recorded.

Invuity (IVTY) Reports Q2 Loss, Lags Revenue Estimates

2018-08-02 zacks
Invuity (IVTY - Free Report) just came out with a quarterly loss of $0.37 per share versus the Zacks Consensus Estimate of a loss of $0.47. This compares to loss of $0.61 per share a year ago. These figures are adjusted for non-recurring items.

Invuity: Turnaround In Progress

2018-07-22 seekingalpha
A secondary offering in March provided them some breathing room and the appointment of Scott Flora as Interim President and Chief Executive Officer was a solid step forward.

Zacks.com featured highlights include: GMS, Invuity, Hi-Crush, Belden and Hubbell

2018-07-17 zacks
Chicago, IL – July 17, 2018 - Stocks in this week’s article GMS Inc. (GMS - Free Report) , Invuity Inc. (IVTY - Free Report) , Hi-Crush Partners LP (HCLP - Free Report) , Belden Inc (BDC - Free Report) and Hubbell Inc (HUBB - Free Report) . (7-0)

5 Top-Ranked Stocks to Ride on Rising P/E Investing

2018-07-16 investorplace
Generally, investors love stocks with a low price-to-earnings (P/E) ratio. The perception is that the lower the P/E, the higher will be the value of the stock. The simple logic that a stock’s current market price does not justify (is not equivalent to) its higher earnings and therefore has room to run is behind investors’ inclination toward low P/E stocks. (3-0)

CUSIP: 46187J205